|
We don't own it... We help you sell it.
|
Login | Register |
|
The Medical Industry Business Weekly |
| August 28, 2008 |
|
Other HeadlinesCompany warns hospitals about unvalidated FirstCall probe files.
UnitedHealth Group of Minneapolis extends imaging accreditation deadline to the fourth quarter of 2009.
CMS releases guide to improve access to navigating Medicare requirements for approving innovative technologies.
Group of organizations discussed radiation dose used in scans performed on children at recent gathering.
With today's technology and treatments, doctors can find and fix osteoporosis.
Have News for Us?Submit your news on the industry, people, or companies.More People & Company HeadlinesMichael Falco Guides Compass Medical in the Right Direction Background in business and finance helps find the right solutions for imaging equipment clientele. Medegen Grows Product Distribution Via Co-Marketing Agreement With Bard MaxPlus® Clear™ Needleless Access Device now available in Bard Peripherally Inserted Central Catheter (PICC) Kits. iCRco Digital Radiography Systems Chosen as Provider to U.S. Military After a rigorous selection process, the U.S. Army has chosen iCRco, a California-based provider of digital x-ray imaging solutions, as its provider for troops injured in battle. NovaRad Secures Contracts With Imaging Centers NovaRad has added four U.S. imaging centers to its roster of NovaPACS users. Misonix, Inc. Enters Two Year Agreement With North Med Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology used in Europe has entered into a distribution agreement with privately-held North Med, based near Prague in the Czech Republic. Baxter Healthcare Corporation Announces Licensing Agreement With Innocoll Pharmaceuticals Ltd. Baxter Healthcare Corporation announced a licensing agreement with Innocoll Pharmaceuticals Ltd, a division of Innocoll, Inc., granting Baxter exclusive rights to market and distribute the company's gentamicin surgical implant in the United States. Cambridge Consultants Develops Instrument to Test Inhalable Drug Delivery Devicesby Joan Trombetti, Writer
Cambridge Consultants is developing a low-cost, portable instrument that could revolutionize the way certain drug delivery devices are tested. The new device can mirror the performance and level of data provided by current laboratory laser diffraction measurement machines, for an estimated one-hundredth of the cost when integrated into a high volume device. It measures the droplet size distribution in an airstream, which is a technique used in testing respiratory drug delivery devices.
Dr. Robert Jones, Senior Consultant at Cambridge Consultants states that this device can achieve in a very simple configuration the multiple angles of combination, wavelength and polarization-state that is needed to get good data from the Mile scatter. He said that the software, developed with this device, is based on Bayesian inference and provides very useful data easily and quickly. The Cambridge Consultants device is based on low-cost LED components, considerably simplified optical configurations and the application of modern signal processing. It is designed to be robust, portable and simple enough to potentially be operated by semi-skilled clinicians, with standard IT equipment to produce highly accurate plots that indicate the number of droplets within a pre-selected range of sizes. Drugs can therefore be tested at the point of delivery, during clinical trials for example, to ensure doses are delivered as intended by the drug developer. For more information visit: www.CambridgeConsultants.com.
Interested in Medical Industry News?
Subscribe to DOTmed's weekly news email and always be informed.
Click here, it takes just 30 seconds.
Please Send us your Comments. |